Back to HHLR Advisors, Ltd. HHLR Advisors, Ltd.

BBIOBBIO

Showing 3 of 24 quarters

Position history for HHLR Advisors, Ltd.HHLR Advisors, Ltd.'s holdings in BridgeBio Pharma, Inc.

No. HHLR Advisors exited its BBIO (BridgeBio Pharma) position in Q1 2025. Its Q4 2024 13F listed 1,023,950 shares worth $28.1M. HHLR Advisors first reported BBIO in Q2 2019 and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$26.1M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$34.57
0
2024-Q4
Unchanged
1M
0.0%
$28.1M1.0%$27.44
0
2024-Q3
Decreased
1M
-26.4%
$26.1M0.6%$25.46
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used